Next Article in Journal
The Antioxidant Effect of Natural Antimicrobials in Shrimp Primary Intestinal Cells Infected with Nematopsis messor
Next Article in Special Issue
Comparative Proteomic Analysis Reveals the Effect of Selenoprotein W Deficiency on Oligodendrogenesis in Fear Memory
Previous Article in Journal
Nitro-Oleic Acid-Mediated Nitroalkylation Modulates the Antioxidant Function of Cytosolic Peroxiredoxin Tsa1 during Heat Stress in Saccharomyces cerevisiae
Previous Article in Special Issue
Reversal of Lipid Metabolism Dysregulation by Selenium and Folic Acid Co-Supplementation to Mitigate Pathology in Alzheimer’s Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Role and Mechanism of Essential Selenoproteins for Homeostasis

Key Laboratory of Precision Nutrition and Food Quality, Ministry of Education, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China
*
Author to whom correspondence should be addressed.
Antioxidants 2022, 11(5), 973; https://doi.org/10.3390/antiox11050973
Submission received: 19 April 2022 / Revised: 5 May 2022 / Accepted: 10 May 2022 / Published: 15 May 2022
(This article belongs to the Special Issue Structure, Function and Biosynthesis of Mammalian Selenoproteins)

Abstract

:
Selenium (Se) is one of the essential trace elements that plays a biological role in the body, mainly in the form of selenoproteins. Selenoproteins can be involved in the regulation of oxidative stress, endoplasmic reticulum (ER) stress, antioxidant defense, immune and inflammatory responses and other biological processes, including antioxidant, anti-inflammation, anti-apoptosis, the regulation of immune response and other functions. Over-loading or lack of Se causes certain damage to the body. Se deficiency can reduce the expression and activity of selenoproteins, disrupt the normal physiological function of cells and affect the body in antioxidant, immunity, toxin antagonism, signaling pathways and other aspects, thus causing different degrees of damage to the body. Se intake is mainly in the form of dietary supplements. Due to the important role of Se, people pay increasingly more attention to Se-enriched foods, which also lays a foundation for better research on the mechanism of selenoproteins in the future. In this paper, the synthesis and mechanism of selenoproteins, as well as the role and mechanism of selenoproteins in the regulation of diseases, are reviewed. Meanwhile, the future development of Se-enriched products is prospected, which is of great significance to further understand the role of Se.

1. Introduction

Selenium (Se), an essential trace element, was first discovered in 1817 and its physiological functions were gradually excavated [1]. Se level is necessary for maintaining homeostasis, including muscle function, male reproductive biology, cardiovascular function, endocrine, the nervous system and especially the immune system [1,2]. The main role of Se can be observed in Figure 1. Se is widely distributed in soil, water, plants, fruits, vegetables, meat, eggs and milk. Dietary Se can be obtained from foods, such as grains, nuts, vegetables, fish, meat, dairy and poultry products [3,4]. Although Se has a good biological activity, amounts that are too low or too high in the body cause adverse effects [2]. Studies have shown that Se deficiency can cause Keshan disease (KD) and Kashin–Beck disease (KBD) [5]. KD is characterized by acute heart failure, congestive heart failure, and arrhythmia. It can also be divided into acute, subacute, chronic and latent KD [6]. KBD can lead to permanent and disabling deformities, including muscular atrophy, hyperplasia, dyskinesia, waddling gait, canard walking, joint linkage, short fingers, short limbs and short stature in some adults. Se supplementation can prevent KD and KBD [7]. However, high Se level can be toxic, engendering symptoms, such as hair loss; brittle, thickened and layered nails; garlicky breath and nervous system abnormalities [1,2].
Se, as a trace element, usually enters the body in the form of organic Se and inorganic Se. Inorganic Se is generally selenate, selenite. Organic Se is selenomethionine (Se-Met) and selenocysteine (Sec) [8,9]. Sec and Se-Met play biological roles in the body. Sec is a translation behavior mediated by codon UGA, and Se-Met binds to protein through methionine. Generally, the proteins formed by Se in the form of Sec are called selenoproteins, while the other forms of protein combined with Se are called se-containing proteins [10]. Selenoproteins can be involved in oxidative stress, endoplasmic reticulum stress and the regulation of immune and hormone levels to affect homeostasis [11]. The expression of selenoproteins is also closely related to the occurrence and development of some diseases [2,10].
Considering the outstanding biological activity of Se, several studies have revealed that Se is involved in regulating the occurrence of many diseases [2]. In addition, there are regional differences in the distribution of Se, so it is particularly important to improve Se level in the body through exogenous Se supplementation in Se-deficient areas [1,3]. Therefore, in addition to studying the specific mechanism of Se and selenoproteins regulating diseases, researchers are gradually focusing on the development of Se-enriched food [12]. Dietary Se supplements are an important method for Se supplementation; researchers have developed many Se-enriched foods, such as Se-enriched rice, Se-enriched apples and Se-enriched eggs with reasonable Se concentrations [12,13,14]. To a certain extent, it is also of great significance for the future research on the rational application of Se and selenoproteins metabolism and physiological functions to improve human and animal health.
The Se element is crucial to organisms. The common forms of Se are selenate, selenite, Sec and Se-Met. Se can resist external stimuli through a variety of signaling pathways to maintain hemostasis. Se can resist external stimuli through a variety of signaling pathways and maintain health, which are mainly reflected in promoting T-cell proliferation and differentiation to play a role in regulating immunity, inhibit the growth and number of tumors for an anticancer effect, regulate the level of inflammatory factors to attain an anti-inflammatory function, reduce the production of ROS and regulate calcium flux to resist ER stress and improve antioxidant capacity to play an antioxidant role. However, due to the limited research on Se, there are still some unrevealed effects of Se, and the potential effects will be discovered in future studies.

2. Synthesis and Metabolism of Selenoproteins

2.1. Diet Sources and Metabolism of Se in the Body

Se, as an essential trace element, plays an important role in the body. The main sources of Se are bread, cereals, eggs, meat, fish, dairy products, fruits and vegetables [1,7,9]. Studies show that the content of Se in food is low and the form of Se is more complex. The qualitative and quantitative analyses of the form of Se in food mainly focus on selenate, selenite, Se-Met, Sec, selenomethylselenocysteine, but the forms of Se in food are far more than these [2,7]. Se consumed by humans through diet is mainly obtained from plants, which absorb various forms of Se from the soil through the roots, and then transform them into organic forms through metabolism, such as Se-Met and Sec amino acids and selenoproteins [4,8,9]. The main absorption site of Se is the small intestine. Se can enter the body through the respiratory tract and skin, and its main absorption site is the small intestine [10]. Se is absorbed by red blood cells soon after intestinal absorption. Through a series of reduction reactions involving glutathione and glutathione reductase, Se is reduced to hydrogen selenide, which becomes the active Se source in selenoprotein synthesis [8]. There are also some differences in the absorption modes of different Se sources. Selenite is absorbed by simple diffusion; organic Se follows the amino acid absorption mechanism [10,15,16]. Se is reduced to hydrogen selenide through a series of reduction reactions involving glutathione and glutathione reductase. Hydrogen selenide is the active Se source in selenoprotein synthesis, and then selenoprotein synthesis is transported to different tissues and organs by the blood for biological activity [16,17,18]. When Se in the body is insufficient, the use of accumulated selenoproteins is preferred. At the same time, under the action of continuous methylation, hydrogen selenide can generate dimethyl and trimethyl Se ions [19]. When the body absorbs excessive Se, it can be metabolized into volatile dimethyl Se and trimethyl Se compounds, which can be excreted through the lung, resulting in garlic breath. Se is excreted from the body mainly through the urine and kidneys, but also in small amounts through feces, sweat and hair [1,8,19]. The detailed metabolic process can be observed in Figure 2.
Se sources (inorganic Se: sodium selenite, selenate; organic Se: Sec, Se-Met) are first converted into selenides for utilization in organisms. Subsequently, selenides are then converted into other forms to be absorbed and used by the body. It is mainly absorbed by the body in the form of selenoproteins, and part of it can be converted into Se-sugar. The unabsorbed selenide forms methyl selenide through methylation, and dimethyl and trimethyl compounds are generated with continuous methylation, which are discharged from the body through respiration, perspiration, urine and feces.

2.2. Se-Synthesis of Selenoproteins

Se can enter the body through various forms of compounds, but is mainly absorbed and utilized in the form of selenoproteins [3]. To date, 25 selenoproteins have been isolated and tested in humans, and 25 selenoproteins have been identified, including 5 glutathione peroxidases (GPXs), 3 thioredoxin reductases (TrxRs), 3 iodothyronine deiodinases (DIOs), selenium phosphorylate synthetase (SPS), selenoprotein H (SELENOH), selenoprotein O (SELENOO), selenoprotein P (SELENOP), selenoprotein T (SELENOT), selenoprotein W (SELENOW), selenoprotein N (SELENON), selenoprotein M (SELENOM), selenoprotein S (SELENOS), selenoprotein I (SELENOI), selenoprotein K (SELENOK), selenoprotein 15 (15kDa), selenoprotein R (SELENOR) and selenoprotein V (SELENOV) [3,17,20]. Se is mainly present in organisms in the form of Sec and Se-Met, which act by binding with proteins. Sec is the 21st naturally occurring amino acid discovered in living organisms [20,21]. It is encoded by the stop codon UGA, and under specific translation conditions [16]. Sec can be transferred to the synthetic selenoprotein polypeptide chain by selenocysteine-specific-transport RNA (tRNAsec). First, the RNA of transported selenocysteine (tRNA[Ser]Sec) was combined with serine and acylated to form Ser-tRNA[Ser]Sec under the action of Serine-tRNA synthase (SERS). Ser-tRNA[Ser]Sec was then phosphorylated by kinase (PSTK) to form pSer-tRNA[Ser]Sec. Finally, Sec synthase (SPS2) catalyzed the formation of Ser-tRNA[Ser]Sec from pSer-tRNA[Ser]Sec and the Se donor H2SePO3− [15,18,21]. Se-Met can be utilized in two ways in the body. Firstly, Se-Met is converted into selenocysteine through the sulfur-conversion pathway to participate in selenoprotein synthesis. Secondly, Se-Met is degraded to methyl selenol by cysteine-γ lyase in vivo, which is converted to dimethyl selenide/trimethyl selenide by methylation with S-adenosine methionine, and then converted to selenide by demethylation to participate in selenoprotein synthesis [5,15,18]. The process of selenoprotein synthesis is detailed in Figure 3.
First, the RNA-transporting selenocysteine (tRNA[Ser]Sec) was acylated with seric acid under the action of Ser-tRNA synthase (SERS) to form Ser-tRNA[Ser]Sec. Ser-tRNA[Ser]Sec was then phosphorylated by kinase (PSTK) to form pSertRNA[Ser]Sec. Finally, Sec synthase (SPS2) promoted pSertRNA[Ser]Sec to form SectRNA[Ser]Sec with the Se donor H2SePO3−. When Se was replaced with sulfur, Sec synthase (SPS2) promoted pSertRNA[Ser]Sec and H2SePO3− to produce Cys-tRNA[Ser]Sec.

3. Selenoproteins Regulate Related Diseases

3.1. Selenoproteins and Cardiovascular Diseases

Se deficiency was first linked to KD, an endemic disease characterized by cardiomyopathy and heart failure [19]. Se deficiency is associated with a variety of cardiovascular diseases, including cardiomyopathy, such as KD, heart failure and myocardial infarction, cardiomyopathy, atherosclerosis and coronary heart disease [22]. Several selenoproteins have been shown to be associated with cardiovascular disease. GPx1 is a stress-responsive selenoprotein, meaning it is tightly regulated by Se levels. Se deficiency may help to down-regulate GPx1 expression, reducing the heart’s ability to respond to oxidative stress and leading to poor cell survival [23]. The primary function of DIO is to regulate thyroid hormone levels, which attenuates cardiac remodeling after myocardial infarction. Reduced plasma levels of the thyroid hormone are associated with heart failure and increased DIO3 expression [24,25]. TrxR mainly regulates intracellular redox reactions and participates in DNA synthesis, immune response and apoptosis in mammals. TrxR, which is subdivided into TrxR1, TrxR2 and TrxR3, plays a role in reducing oxidative stress to hypertrophy caused by stress overload and improving left ventricular remodeling [26,27]. T. A. et al. showed that SELENOT prevented the free-radical damage of cell death during ischemia/reperfusion. SELENOT-derived peptides protect the heart from ischemia-reperfusion injury by inhibiting apoptosis and oxidative stress [28]. ER stress is an important factor in regulating cardiac apoptosis/survival decisions during various stress processes. SELENOK is also associated with SELENOS regulating ER stress induced by misfolded proteins. In addition, SELENOM, SELENON and Sep15 are present in ER and may regulate cardiac response to ER stress [29,30,31].

3.2. Selenoproteins and Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is often complex and often associated with serious complications, such as obesity and/or insulin resistance, and has become the most common chronic liver disease in the world. High-plasma Se and SELENOP levels are associated with insulin resistance and NAFLD, the SELENOP level was positively correlated with insulin resistance and NAFLD, but for serum Se, the conclusions were different [32,33]. An. et al. showed that adding 1.0 mg/kg of Se can reduce the liver injury induced by high fat [34]. The mRNA level of SELENOS in the liver of pigs induced by high fat can be significantly increased, and the expression of SELENOS is negatively correlated with the trend of apoptosis rate and symptoms of non-alcoholic steatohepatitis. This also suggests that SELENOS may be essential in the protection of liver damage induced by high fat [34,35]. The liver, as the central organ of Se regulation, regulates the Se level of the whole body by forming SELENOP and then transports it to other organs [33]. Studies have shown that dietary Se deficiency can reduce liver selenase activity and lead to oxidative stress, and activate oxidative stress-related signals through [36,37]. Se deficiency induces redox imbalance by regulating selenoproteins at mRNA and protein levels, thereby blocking the GSH system while enhancing GSH synthesis and catabolism [37]. Se and selenoproteins play an immunomodulatory role in hepatocellular carcinoma (HCC) by regulating oxidative stress, inflammation, immune response, cell proliferation and growth, angiogenesis, signaling pathways and apoptosis [36,38]. Sang et al. showed that Se concentration was usually low in the tissues of HCC patients, and Se concentration in the tissues of HCC patients could be higher by exogenous Se supplementation than before, thus reducing the number and size of tumors [38].

3.3. Selenoproteins and Brain Diseases

Most expression of selenoproteins are proven in the brain, especially in cortex and hippocampus neuron dysfunction [39,40]. Studies have found that selenoproteins can lead to impaired cognitive function and neural systemic disease [41,42,43]; existing research has shown that selenoproteins in brain diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD), play an important role in epilepsy [44,45,46]. Selenoproteins are important for normal brain function, and a decline in their function can lead to impaired cognitive function and neurological diseases [40,43]. Se deficiency has been associated with cognitive decline, and selenoproteins may help prevent the neurodegeneration of AD [45]. PD is associated with the impaired function of glutathione peroxidase selenase [46]. In HD, Se prevents lipid peroxidation by increasing specific glutathione peroxidase enzymes [47]. Se deficiency can increase the risk of seizures, and Se supplements may help alleviate them. SELENOP plays a crucial role in Se homeostasis in the brain, and GPx1 and GPx4 are the main forms of GPx in the brain. GPx4 functions at different sites in neurons, including cytosol, mitochondria and the nucleus [41,43,47]. GPx4 destroys phospholipid hydroperoxides and, together with vitamin E, inhibits lipid peroxidation in various cell membranes and lipoproteins. GPx4 has a potential role in AD, epilepsy and HD [45,46,47]. TrxR related to brain function is mainly TrxR1 and TrxR2. They reduce hydrogen peroxide and oxidative stress, and regulate redox sensitive transcription factors that control cellular transcription mechanisms. The protein family may have a protective role in AD and epilepsy [39,41,43,48].

3.4. Selenoproteins and Intestinal Diseases

Gastrointestinal diseases have become one of the most important diseases threatening global health, and there is no complete cure at present, so the research on intestinal tracts is particularly urgent [49]. A large number of recent studies have linked Se levels to the incidence and severity of intestinal diseases, such as inflammatory bowel disease (IBD) and colorectal cancer (CRC) [50]. Se alleviates intestinal inflammation through the action of selenoproteins, which play a protective role in intestinal infection by strengthening type-3 innate lymphocytes (ILC3) and helper T-cells 17 (Th17), which are required by the intestinal epithelial barrier [51,52]. The intestinal barrier is necessary to maintain intestinal function. There are many factors that can lead to intestinal barrier damage [53], among which inflammation can increase the production of ROS and damage the intestinal barrier, while dietary Se supplementation can reduce the level of ROS [54]. With the antioxidant function of selenoproteins that can play roles in intestinal inflammation, spontaneous colitis can be induced in GPx1 and GPx2 knockout mice [55]. In vitro and in vivo studies of Sep15 knockout colon cancer cells or mouse models using systemic knockout Sep15 observed a reversal of colon cancer phenotype and a reduction in the number of chemically induced tumors, respectively [56,57]. SELENOP, one of the most important selenoproteins, is significantly reduced in the serum of CD, and serum SELENOP concentration is negatively correlated with CRC risk [22]. C.S.W. et al. demonstrated that SELENOP of colonic epithelial origin is the source of antioxidant-mediated cancer protection associated with colitis, and that SELENOP down-regulation promotes oxidative stress in ulcerative colitis (UC) [58]. Intestinal epithelial conditional deletion increases tumor load and genomic instability in the CAC model, suggesting an important role of SELENOP in colon cancer development [51,58]. In addition, reduced Se levels promote T-assisted (Th1) cell differentiation in CD patients. Se supplementation can inhibit Th1 cell differentiation through SELENOW, and significantly remove cytoplasmic ROS, and relieve symptoms of patients with CD [59].

3.5. Selenoproteins and Cancer

Many studies have revealed that selenoproteins are closely related to the occurrence of tumor and the progression of cancer [3,20,22]. CRC is one of the most common cancer diseases and one of the most common causes of death. It is well known that both genetic and environmental factors contribute to the increased incidence and mortality from CRC [60,61]. As a kind of important selenoprotein, GPx can play a role in a variety of cancers [62,63]. The down-regulation of GPx1 can promote the development of breast, lung and head and neck cancers. The down-regulation of GPx1, GPx3 and SELENOP is associated with the tumogenesis of colon cancer [51,58,62,63]. As an important ER-resident protein, Sep15 can be highly expressed in a variety of organs, and it is down-regulated in liver, prostate, breast and lung cancers [64,65,66,67,68]. SELENOP, as the main selenoprotein in plasma, plays an important role in the development of colon cancer, and the down-regulation of SELENOP can promote the occurrence of colorectal cancer [58]. SELENOK negatively regulates human chorionic gonadotropin β subunit (β-HCG expression) and acts as a tumor suppressor in human choriocarcinoma cells, which may be a novel therapeutic target for human choriocarcinoma in vitro [69]. SELENOK can inhibit cell adhesion and the migration of human gastric cancer cells. SELENOK is critical in promoting calcium fluxes that induce melanoma progression [70,71]. The up-regulation of GPx2 and Sep15 was observed in bladder tumors and bladder cancer cells [59]. Due to the limited research on selenoproteins, the relationship between selenoproteins and cancer has not yet been revealed.

3.6. Selenoproteins and Reproduction

Se has a significant effect on the enzyme system of the male reproductive tract, and a lack of Se can affect testicular growth and delayed puberty [3]. Se plays an important role in sperm maturation in mammals, and Se deficiency can block sperm maturation [72]. Se level can affect semen quality and fertility; the process of sperm maturation affects male reproduction ability, so the Se level is necessary in male reproduction [73,74]. Se, as a component of selenoproteins and selenase, is involved in spermatogenesis by protecting sperm from ROS [73]. Selenoprotein knockout studies have shown that a lack of selenoproteins during spermatogenesis can lead to sperm abnormalities, which, in turn, affects semen quality and fertility [72]. Therefore, appropriate Se levels in the body are crucial for maintaining male reproductive function and avoiding infertility [71,72]. Se deficiency can reduce levels of selenoproteins involved in redox regulation, impair placental function and fetal development, and lead to miscarriage or complex preterm birth [73]. Thyroid hormone is essential for mammalian reproduction and growth [74]. DIO regulates thyroid hormone synthesis, and inadequate thyroid hormone synthesis has been associated with decreased fertility, disrupted estrus cycles, implantation dysfunction and uterine structural defects in humans and rodents, as well as other problems related to pregnancy health [73,75]. Selenoproteins are highly expressed in female reproductive tissues and play a role in follicular development and ovarian function [76].
Selenoproteins can regulate homeostasis by regulating multiple tissues and organs in the body, and its participation in the regulation of major organs can be observed in Figure 4.
Selenoproteins are involved in the regulation of multiple tissues and organs to maintain homeostasis. DIO can regulate thyroid hormone levels, and decreased plasma levels of the thyroid hormone are associated with increased DIO3 expression. ER-resident proteins in selenoproteins can regulate ER oxidative stress and alleviate the damage caused by oxidative stress. Selenoproteins can also regulate intestinal health by regulating the production of reactive oxygen species and inflammatory response, and alleviate the development of diseases, such as in the nervous system. In addition, selenoproteins are also important in cancer and reproduction. Selenoproteins can affect the maturation process of sperm, which affects sperm motility and thus fertility. Moreover, many studies have shown that selenoproteins are closely involved in the development of cancer.

4. Mechanisms That Show That Selenoproteins Regulate Disease

Selenoproteins can be involved in regulating cellular oxidative stress, ER stress, antioxidant defense, immune response, inflammatory response and other biological processes in the body [1,3,22,74], including antioxidant, anti-inflammation, anti-apoptosis, and regulating immune response and other functions. Selenoproteins regulate body health in various and complex ways [5,18,20].

4.1. Selenoproteins Regulate Immune Responses

Immune responses are often closely related to inflammatory processes, and are also associated with ROS production and redox processes [20]. Se and selenoproteins regulate inflammatory and immune processes through redox function [77]. White blood cells, such as lymphocytes, macrophages and neutrophils, require ROS and pro-inflammatory molecules for activation, differentiation and phagocytosis [2]. The production of ROS increases the expression of inflammatory cytokines by increasing NF-κB activity. Because selenoproteins may affect these signaling pathways, they are also important in regulating immune responses and inflammation [78,79,80]. SELENOK is essential for calcium flux, T-cell proliferation and neutrophil migration in immune cells and has been shown to protect cells from ER stress-induced apoptosis [34]. Graves’ disease (GD) and Hashimoto’s thyroiditis (HT) are the most common autoimmune thyroid diseases (AITDs) [77]. Serum Se concentration in patients with autoimmune thyroid disease is reduced, and Se supplementation in patients with AITD can change inflammation and immune response to a certain extent. The main mechanisms involved include enhanced plasma GPX and TrxR activity and reduced toxicity of hydrogen peroxide and lipid hydroperoxides [78]. The researchers also found that MsrB1 controls immune responses by promoting the expression of anti-inflammatory cytokines in macrophages [80]. P.R. H. et al. found that SELENOK plays an important non-enzymatic role in regulating immunity as a cofactor of enzymes involved in key post-translational modifications of proteins. It also has a high catalytic efficiency and can play a biological role through antioxidant and protein repair [81]. The thymus and spleen are major reservoirs of T lymphocytes that regulate innate immune responses and provide protection against pathogens and tissue damage [82]. Feng et al. increased antioxidant capacity and selenoprotein expressions in offspring thymus and spleen through the maternal exogenous supplementation of organic Se sources, and reduced inflammation, autophagy and endoplasmic reticulum stress levels in offspring thymus and spleen [83].

4.2. Selenoproteins Reduce Inflammation

GPx1, as one of the important antioxidant enzymes in the body, can reduce the accumulation of pro-inflammatory factors and enhance the antioxidant capacity of the body, and its expression is affected by the Nrf2/ARE pathway [84]. ROS is produced under intracellular aerobic conditions and participates in cell proliferation, differentiation, apoptosis and other physiological activities. The main function of GPx is to remove ROS, including superoxide anions, hydrogen peroxide and hydroxyl radicals, and regulate the balance of intracellular redox [85]. GPx can catalyze glutathione in a variety of tissue cells, reduce peroxide to the corresponding alcohol, reduce oxidative stress and DNA oxidative damage, prevent free radicals from producing peroxidation and thus reduce the incidence of cell mutation [17,22]. Studies have shown that dietary Se supplementation can improve the activities of antioxidant enzymes, such as GPx and SOD, reduce the level of MDA and reduce DNA damage and cell apoptosis caused by oxidative stress [83,84]. GPx2 and GPx1 are important regulatory factors of epithelial cells and may affect inflammatory responses, and speculate that GPx1 and GPx2 have certain protective functions in colitis and inflammation-driven carcinogenesis [55,62,86]. Se and selenoproteins affect the immune response and epithelial barrier integrity after intestinal infection, mainly by regulating the mechanisms of ILC3 and Th17 cells to reduce inflammation and infection [51,52]. Se deficiency can target vascular tissue and mediate vascular injury through multiple pathways, such as necrosis, apoptosis and inflammation [85,87]. In vascular endothelial cells, increased selenoproteins activity may play a protective role by reducing abnormal cell adhesion induced by pro-inflammatory cytokines [30,31]. Additionally, the down-regulation of SELENOS under Se deficiency can effectively prevent the development of cardiovascular diseases, such as atherosclerosis and hypertension [87]. Selenoproteins protect the heart by damaging cholesterol that accumulates in blood vessel walls, increasing levels of coenzyme A in the heart muscle and increasing energy production [29].

4.3. Selenoproteins Inhibit ER Stress

ER is widely distributed in eukaryotic cells and plays an important role in protein processing, modification and steroid synthesis [87]. When there are too many unfolded or misfolded proteins in RE for a long period of time, calcium homeostasis imbalance can lead to an ER stress response. If it is not regulated, the ER activates the corresponding signaling pathway and induces apoptosis [88]. A variety of selenoproteins have an ER-response excitation adjustment function. Resident selenoproteins that regulate ER stress include 15 kDa selenoproteins, DIO2, SELENOS, SELENON, SELENOK, SELENOM and SELENOT [28,57,89,90]. ER-resident selenoproteins are involved in oxidative and ER stress, inflammation and/or intracellular Ca2+ homeostasis [91,92]. ER-resident selenoproteins are involved in homeostasis by regulating Ca2+ flux. SELENON appears to act as a redox cofactor for raniline receptors [89], while the redox enzyme Sep15 is associated with proteins involved in protein-folding quality control [56]. DIO2 is involved in thyroid hormone metabolism and also catalyzes redox reactions [8]. Future research will further reveal the mechanism of action of ER-resident proteins.
Selenoproteins play biological roles by regulating a variety of signaling pathways, and the detailed regulatory mechanisms can be observed in Figure 5.
GPx1, as one of the important selenoproteins, can reduce the accumulation of pro-inflammatory factors and enhance the antioxidant capacity of the body, and its expression is affected by the Nrf2/ARE pathway. When the body is subjected to oxidative stress, Nrf2 uncouples from the Keap1 protein, enters the nucleus and binds to ARE, activates the Nrf2/ARE pathway, enhances downstream GPx1 gene expression and alleviates oxidative stress. The expression of selenoprotein can reduce the expression of inflammatory factors, reduce the phosphorylation levels of IκK, IκBα and NF-κB P65, inhibit the production of pro-inflammatory factor NO and alleviate the pro-inflammatory response caused by oxidative stress. NADPH oxidase (NOX) can mediate excessive ROS production and induce ER oxidative stress, while selenoprotein can inhibit ROS production and relieve ER stress. In addition, selenoproteins can improve the antioxidant capacity of the body and cells by up-regulating the expression of DNA Methyltransferase 1 (DNMT1), block DNA oxidative damage and alleviate the toxic effect of cells. Selenoproteins maintain homeostasis through the regulation of various disease-related pathways.

5. Future Development Trend of Se and Selenoproteins

5.1. Se-Enriched Food Industry Develops Vigorously

Se is an essential trace element in the diet and is necessary for health and growth. It has been proved that the bioavailability of organic Se is higher than that of inorganic Se [1,8,10]. With the continuous improvement of living standards, people pay increasingly more attention to health. Considering the powerful antioxidant, anti-inflammatory and anti-cancer functions of Se, as well as the high biological activity of organic Se [6,20,22], the development and commercialization of organic Se reveals a new era of Se-enriched products. The existence of Se-deficiency areas makes the exogenous Se supplement particularly important; the intake of Se-enriched food (meat, milk and eggs) can be used to improve Se levels in the body [11,12,14]. Se intake by plants is mainly from the environment [9]. For vegetables, the Se intake from the environment is minor, and Se treatment can significantly improve the Se accumulation in plants [7]. Se fortification can have a positive effect on the quality of plant food [93]. Some studies have shown that appropriate levels of Se can partially reduce chloroplast degradation and increase chlorophyll content [94,95,96]. Se treatment significantly improves the vegetative growth and photosynthetic pigment accumulation of peanut plants [94], and Se supplementation could effectively improve the antioxidant capacity of broccoli, improve growth performance and increase Se concentration [89]. In addition, eating Se-enriched foods can improve the body’s antioxidant and anti-inflammatory abilities to resist external damage [88,89,90]. Studies have shown that Se-enriched radish sprouts can inhibit inflammation and reduce cell apoptosis to alleviate liver injury induced by carbon tetrachloride [95]. Eating Se-enriched lentils can increase the excretion of heavy-metal arsenic and maintain the health level of the body [96]. The consumption of Se-enriched fruits may contribute to daily Se supplementation, thereby improving human health [13]. Se-enriched kiwifruit (Se-Kiwi) can significantly improve the activity of antioxidant enzymes in the liver of hyperlipidemia mice, reduce the content of liver fat, inhibit the accumulation of abdominal-fat cells and restore the shape of liver to a healthy level [97]. Se is usually used as a feed additive to improve feed efficiency and growth, carcass traits and the meat quality of livestock and poultry [98]. Adding a proper Se source to the feed of laying hens can increase the Se concentration in eggs and obtain Se-enriched eggs [98,99]. Dietary supplementation of Se-enriched yeast can activate glutathione and the thioredoxin system to improve meat quality and enhance the total antioxidant capacity of broilers [100,101]. Adding olive leaves supplemented with Se to a rabbit’s diet can improve the oxidation state and antioxidant content of rabbit meat [102]. It was found that eating Se-enriched pork can increase serum Se from 73.19 ± 15.68 μg.L−1 to 73.73 ± 15.13 μg.g L−1, and reduce the total cholesterol level in the human body [103]. However, it should be noted that, even though Se plays an important role in the body, an excessive Se content in the body causes Se poisoning, so the doses of Se in production and application should be strictly controlled [96,97,98,99,100,101].

5.2. Nano-Se Has the Potential to Be a High-Quality Se Supplement

Because traditional Se supplements usually have the disadvantages of low absorption and toxicity, it is of great significance to develop a novel Se transporter [1]. Nano-Se is zero-oxidation valence Se (Se 0). In comparison to the other oxidation states (Se + IV, Se + VI), Nano-Se has a low toxicity and excellent bioavailability [104,105]. It is also very unstable and easily converted to other forms of Se. However, its stability can be achieved by encapsulation into suitable nano-carriers, such as polysaccharides, polyphenols, proteins and microorganisms [106]. Nano-Se can be synthesized by chemical, physical and biological syntheses. The synthesis process is simple, efficient and green [104]. Nano-Se can be used as an antioxidant to resist external stimuli and promote the expression of selenoproteins [107]. Nano-Se also has antiviral and antibacterial effects and has a potential in the treatment of cancer. In addition to its direct anti-cancer effect, it can also be used as a delivery carrier for anti-cancer drugs [103], which is of great significance for the prevention of cancer. Nano-Se has a great potential as a high-quality dietary-supplement source of Se [13,108]. However, it should be noted that, although Nano-Se plays an important role in maintaining the body’s health, its possible toxicity and side effects as a nutritional supplement should be further verified.

6. Conclusions and Future Outlook

Se has strong biological activity and is essential to the body. Selenoproteins, as the main utilization form of Se, participate in the regulation of multiple signaling pathways to resist external stimuli. However, special attention should be paid to Se that can be used as a “double-edged sword” element; a lack or overload of Se can have adverse effects on the body. In addition, some mechanisms of Se and selenoproteins in the regulation of diseases have not been clarified. Therefore, future research should focus on the specific mechanism of Se’s participation in regulating diseases after entering the body. This paper reviewed the biological function of Se and the role of Se in the body’s health, which provides a reference for the comprehensive study of the mechanism of Se in the future.

Author Contributions

Conceptualization, R.Y. and Y.D.; methodology, R.Y. and Y.D.; formal analysis, R.Y.; writing—original draft preparation, R.Y.; writing—review and editing, J.H. and Y.D.; visualization, Z.W.; supervision, Y.C.; funding acquisition, Y.D. All authors have read and agreed to the published version of the manuscript.

Funding

The present study was supported by the National Natural Science Foundation of China (grant nos. 31972633, 31572476, 31272483) and the National Natural Science Foundation of Beijing (grant nos. 6212018, 6194031, 6172022).

Conflicts of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Abbreviations

Selenium: Se; endoplasmic reticulum: ER; selenocysteine: Sec; selenomethionine: Se-Met; GPX: glutathione peroxidase; thioredoxin reductase: TrxR; iodothyronine deiodinase: DIO; selenium phosphorylates synthetase: SPS; selenoprotein H: SELENOH; selenoprotein O: SELENOO; selenoprotein P: SELENOP; selenoprotein T: SELENOT; selenoprotein W: SELENOW; selenoprotein N: SELENON; selenoprotein M: SELENOM; selenoprotein S: SELENOS; selenoprotein I: SELENOI; Selenoprotein K: SELENOK; selenoprotein 15: 15 kDa; selenoprotein R: SELENOR; selenoprotein V: SELENOV; non-alcoholic fatty liver disease: NAFLD; hepatocellular carcinoma: HCC; Alzheimer’s disease: AD; Parkinson’s disease: PD; Huntington’s disease: HD; inflammatory bowel disease: IBD; colorectal cancer: CRC; type-3 innate lymphocytes: ILC3; helper T-cells 17: Th17; reactive oxygen species: ROS; Graves’ disease: GD; Hashimoto’s thyroiditis: HT; autoimmune thyroid diseases: AITD; lipopolysaccharide: LPS; Se-enriched kiwifruit: Se-Kiwi.

References

  1. Rayman, M.P. Selenium and human health. Lancet 2012, 379, 1256–1268. [Google Scholar] [CrossRef]
  2. Rayman, M.P. The importance of selenium to human health. Lancet 2000, 356, 233–241. [Google Scholar] [CrossRef] [Green Version]
  3. Kieliszek, M. Selenium(-)fascinating microelement, properties and sources in food. Molecules 2019, 24, 1298. [Google Scholar] [CrossRef] [Green Version]
  4. Dinh, Q.T.; Cui, Z.; Liang, D. Selenium distribution in the Chinese environment and its relationship with human health: A review. Environ. Int. 2018, 112, 294–309. [Google Scholar] [CrossRef]
  5. Liu, X.; He, S.; Tan, W. Expression profile analysis of selenium-related genes in peripheral blood mononuclear cells of patients with Keshan disease. Biomed Res. Int. 2019, 2019, 4352905. [Google Scholar] [CrossRef]
  6. Wang, K.; Yu, J.; Sun, D. Endemic Kashin-Beck disease: A food-sourced osteoarthropathy. Semin. Arthritis Rheum. 2020, 50, 366–372. [Google Scholar] [CrossRef]
  7. Wang, L.; Yin, J.; Guo, X. Serious selenium deficiency in the serum of patients with kashin-beck disease and the effect of nano-selenium on their chondrocytes. Biol. Trace Elem. Res. 2020, 194, 96–104. [Google Scholar] [CrossRef]
  8. Hadrup, N.; Ravn-Haren, G. Absorption, distribution, metabolism and excretion (ADME) of oral selenium from organic and inorganic sources: A review. J. Trace Elem. Med. Biol. 2021, 67, 126801. [Google Scholar] [CrossRef]
  9. Mehdi, Y.; Hornick, J.L.; Dufrasne, I. Selenium in the environment, metabolism and involvement in body functions. Molecules 2013, 8, 3292–3311. [Google Scholar] [CrossRef] [Green Version]
  10. Lu, J.; Holmgren, A. Selenoproteins. J. Biol. Chem. 2009, 284, 723–727. [Google Scholar] [CrossRef] [Green Version]
  11. Labunskyy, V.M.; Hatfield, D.L.; Gladyshev, V.N. Selenoproteins: Molecular pathways and physiological roles. Physiol. Rev. 2014, 94, 739–777. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Zeng, R.; Farooq, M.U.; Zhu, J. Dissecting the potential of selenoproteins extracted from selenium-enriched rice on physiological, biochemical and anti-ageing effects in vivo. Biol. Trace Elem. Res. 2020, 196, 119–130. [Google Scholar] [CrossRef] [PubMed]
  13. Xu, X.; Bao, Y.; Wu, J. Chemical analysis and flavor properties of blended orange, carrot, apple and Chinese jujube juice fermented by selenium-enriched probiotics. Food Chem. 2019, 289, 250–258. [Google Scholar] [CrossRef] [PubMed]
  14. Adadi, P.; Barakova, N.V.; Krivoshapkina, E.F. Designing selenium functional foods and beverages: A review. Food Res. Int. 2019, 120, 708–725. [Google Scholar] [CrossRef]
  15. Hoffmann, P.R.; Berry, M.J. Selenoprotein synthesis: A unique translational mechanism used by a diverse family of proteins. Thyroid 2005, 15, 769–775. [Google Scholar] [CrossRef]
  16. Bulteau, A.L.; Chavatte, L. Update on selenoprotein biosynthesis. Antioxid. Redox Signal. 2015, 23, 775–794. [Google Scholar] [CrossRef]
  17. Santesmasses, D.; Mariotti, M.; Gladyshev, V.N. Bioinformatics of selenoproteins. Antioxid. Redox Signal. 2020, 33, 525–536. [Google Scholar] [CrossRef]
  18. Sunde, R.A.; Raines, A.M. Selenium regulation of the selenoprotein and nonselenoprotein transcriptomes in rodents. Adv. Nutr. 2011, 2, 138–150. [Google Scholar] [CrossRef] [Green Version]
  19. Schweizer, U.; Dehina, N.; Schomburg, L. Disorders of selenium metabolism and selenoprotein function. Curr. Opin. Pediatr. 2011, 23, 429–435. [Google Scholar] [CrossRef]
  20. Papp, L.V.; Lu, J.; Khanna, K.K. From selenium to selenoproteins: Synthesis, identity, and their role in human health. Antioxid. Redox Signal. 2007, 9, 775–806. [Google Scholar] [CrossRef]
  21. Schoenmakers, E.; Chatterjee, K. Human disorders affecting the selenocysteine incorporation pathway cause systemic selenoprotein deficiency. Antioxid. Redox Signal. 2020, 33, 481–497. [Google Scholar] [CrossRef]
  22. Rayman, M.P. Food-chain selenium and human health: Emphasis on intake. Br. J. Nutr. 2008, 100, 254–268. [Google Scholar] [CrossRef] [Green Version]
  23. Yoshida, T.; Watanabe, M.; Das, D.K. Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J. Mol. Cell Cardiol. 1996, 28, 1759–1767. [Google Scholar] [CrossRef]
  24. Rose, A.H.; Hoffmann, P.R. Selenoproteins and cardiovascular stress. Thromb. Haemost. 2015, 113, 494–504. [Google Scholar] [CrossRef]
  25. Shimada, B.K.; Alfulaij, N.; Seale, L.A. The impact of selenium deficiency on cardiovascular function. Int. J. Mol. Sci. 2021, 22, 10713. [Google Scholar] [CrossRef]
  26. Yamamoto, M.; Yang, G.; Sadoshima, J. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J. Clin. Investg. 2003, 112, 1395–1406. [Google Scholar] [CrossRef]
  27. Yang, J.; Hamid, S.; Zhang, Z. Gene expression of selenoproteins can be regulated by thioredoxin(Txn) silence in chicken cardiomyocytes. J. Inorg. Biochem. 2017, 177, 118–126. [Google Scholar] [CrossRef]
  28. Rocca, C.; Boukhzar, L.; Angelone, T. A selenoprotein T-derived peptide protects the heart against ischaemia/reperfusion injury through inhibition of apoptosis and oxidative stress. Acta. Physiol. 2018, 223, e13067. [Google Scholar] [CrossRef]
  29. Shalihat, A.; Hasanah, A.N.; Gozali, D. The role of selenium in cell survival and its correlation with protective effects against cardiovascular disease: A literature review. Biomed. Pharmacother. 2021, 134, 111125. [Google Scholar] [CrossRef]
  30. Rees, K.; Hartley, L.; Stranges, S. Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2013, 2013, CD009671. [Google Scholar] [CrossRef] [Green Version]
  31. Benstoem, C.; Goetzenich, A.; Stoppe, C. Selenium and its supplementation in cardiovascular disease—What do we know? Nutrients 2015, 7, 3094–3118. [Google Scholar] [CrossRef] [Green Version]
  32. Caviglia, G.P.; Rosso, C.; Bugianesi, E. Interplay between oxidative stress and metabolic derangements in non-alcoholic fatty liver disease: The role of Selenoprotein P. Int. J. Mol. Sci. 2020, 21, 8838. [Google Scholar] [CrossRef]
  33. Day, K.; Seale, L.A.; Cardoso, B.R. Selenotranscriptome network in non-alcoholic fatty liver DISEASE. Front. Nutr. 2021, 8, 744825. [Google Scholar] [CrossRef]
  34. Wang, P.; Lu, Z.; Shan, A. The effects of endoplasmic-reticulum-resident selenoproteins in a nonalcoholic fatty liver disease pig model induced by a high-fat diet. Nutrients 2020, 12, 692. [Google Scholar] [CrossRef] [Green Version]
  35. Speckmann, B.; Schulz, S.; Kipp, A.P. Selenium increases hepatic DNA methylation and modulates one-carbon metabolism in the liver of mice. J. Nutr. Biochem. 2017, 48, 112–119. [Google Scholar] [CrossRef]
  36. Lennicke, C.; Rahn, J.; Seliger, B. Individual effects of different selenocompounds on the hepatic proteome and energy metabolism of mice. Biochim. Biophys. Acta. Gen. Subj. 2017, 1861, 3323–3334. [Google Scholar] [CrossRef] [Green Version]
  37. Tang, C.; Li, S.; Zhang, J. Selenium deficiency-induced redox imbalance leads to metabolic reprogramming and inflammation in the liver. Redox Biol. 2020, 36, 101519. [Google Scholar] [CrossRef]
  38. Wu, B.K.; Chen, Q.H.; Sang, L.X. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancer. Int. Immunopharmacol. 2021, 96, 107790. [Google Scholar] [CrossRef]
  39. Cardoso, B.R.; Roberts, B.R.; Hare, D.J. Selenium, selenoproteins and neurodegenerative diseases. Metallomics 2015, 7, 1213–1228. [Google Scholar] [CrossRef] [Green Version]
  40. Pitts, M.W.; Hoffmann, P.R.; Schomburg, L. Editorial: Selenium and selenoproteins in brain development, function, and disease. Front. Neurosci. 2022, 15, 821140. [Google Scholar] [CrossRef]
  41. Steinbrenner, H.; Sies, H. Selenium homeostasis and antioxidant selenoproteins in brain: Implications for disorders in the central nervous system. Arch. Biochem. Biophys. 2013, 536, 152–157. [Google Scholar] [CrossRef] [PubMed]
  42. Chen, J.; Berry, M.J. Selenium and selenoproteins in the brain and brain diseases. J. Neurochem. 2003, 86, 1–12. [Google Scholar] [CrossRef] [PubMed]
  43. Pillai, R.; Uyehara-Lock, J.H.; Bellinger, F.P. Selenium and selenoprotein function in brain disorders. IUBMB Life 2014, 66, 229–239. [Google Scholar] [CrossRef] [PubMed]
  44. Zhang, S.; Rocourt, C.; Cheng, W.H. Selenoproteins and the aging brain. Mech. Ageing Dev. 2010, 131, 253–260. [Google Scholar] [CrossRef] [PubMed]
  45. Zhang, Z.H.; Song, G.L. Roles of selenoproteins in brain function and the potential mechanism of selenium in alzheimer’s disease. Front. Neurosci. 2021, 15, 646518. [Google Scholar] [CrossRef] [PubMed]
  46. Zhang, X.; Liu, R.P.; Zhu, J.H. Prioritized brain selenium retention and selenoprotein expression: Nutritional insights into Parkinson’s disease. Mech. Ageing Dev. 2019, 180, 89–96. [Google Scholar] [CrossRef]
  47. Whanger, P.D. Selenium and the brain: A review. Nutr. Neurosci. 2001, 4, 81–97. [Google Scholar] [CrossRef]
  48. Solovyev, N.D. Importance of selenium and selenoprotein for brain function: From antioxidant protection to neuronal signalling. J. Inorg. Biochem. 2015, 153, 1–12. [Google Scholar] [CrossRef]
  49. Kaplan, G.G. The global burden of IBD: From 2015 to 2025. Nat. Rev. Gastroenterol. Hepatol. 2015, 12, 720–727. [Google Scholar] [CrossRef]
  50. Barrett, C.W.; Short, S.P.; Williams, C.S. Selenoproteins and oxidative stress-induced inflammatory tumorigenesis in the gut. Cell Mol. Life Sci. 2017, 74, 607–616. [Google Scholar] [CrossRef] [Green Version]
  51. Short, S.P.; Pilat, J.M.; Williams, C.S. Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease. Free Radic. Biol. Med. 2018, 1, 26–35. [Google Scholar] [CrossRef] [PubMed]
  52. Carlson, B.A.; Prabhu, K.S. The essential role of selenoproteins in the resolution of Citrobacter rodentium-induced intestinal inflammation. Front. Nutr. 2020, 7, 96. [Google Scholar]
  53. Peterson, L.W.; Artis, D. Intestinal epithelial cells: Regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 2014, 14, 141–153. [Google Scholar] [CrossRef] [PubMed]
  54. Zhuang, Y.; Wu, H.; Yin, Y. Resveratrol attenuates oxidative stress-induced intestinal barrier injury through PI3K/Akt-mediated Nrf2 signaling pathway. Oxid. Med. Cell Longev. 2019, 2019, 7591840. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Steven, E.R.; Kim, B.W.; Chu, F.F. The Gdac1 locus modifies spontaneous and Salmonella-induced colitis in mice deficient in either Gpx2 or Gpx1 gene. Free Radic. Biol. Med. 2013, 65, 1273–1283. [Google Scholar] [CrossRef] [Green Version]
  56. Tsuji, P.A.; Carlson, B.A.; Davis, C.D. Knockout of the 15 kDa selenoprotein protects against chemically-induced aberrant crypt formation in mice. PLoS ONE 2012, 7, e50574. [Google Scholar] [CrossRef]
  57. Nettleford, S.K.; Zhao, L.; Tsuji, P.A. Selenium and the 15kDa selenoprotein impact colorectal tumorigenesis by modulating intestinal barrier integrity. Int. J. Mol. Sci. 2021, 22, 10651. [Google Scholar]
  58. Short, S.P.; Pilat, J.M.; Williams, C.S. Colonic epithelial-derived selenoprotein P is the source for antioxidant-mediated protection in colitis-associated cancer. Gastroenterology 2021, 160, 1694–1708. [Google Scholar] [CrossRef]
  59. Huang, L.J.; Mao, X.T.; Cao, Q. Multiomics analyses reveal a critical role of selenium in controlling T cell differentiation in Crohn’s disease. Immunity 2021, 54, 1728–1744. [Google Scholar] [CrossRef]
  60. Tsuji, P.A.; Naranjo-Suarez, S.; Davis, C.D. Deficiency in the 15 kDa selenoprotein inhibits human colon cancer cell growth. Nutrients 2011, 3, 805–817. [Google Scholar] [CrossRef] [Green Version]
  61. Murawaki, Y.; Tsuchiya, H.; Shiota, G. Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett. 2008, 259, 218–230. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Reszka, E. Selenoproteins in bladder cancer. Clin. Chim. Acta. 2012, 413, 847–854. [Google Scholar] [CrossRef] [PubMed]
  63. Keum, N.; Giovannucci, E. Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies. Nat. Rev. Gastroenterol. Hepatol. 2019, 16, 713–732. [Google Scholar] [CrossRef] [PubMed]
  64. Xi, Y.; Xu, P. Global colorectal cancer burden in 2020 and projections to 2040. Transl. Oncol. 2021, 14, 101174. [Google Scholar] [CrossRef]
  65. Wei, R.; Qiu, H.; Gan, Z. Expression and prognostic potential of GPX1 in human cancers based on data mining. Ann. Transl. Med. 2020, 8, 124. [Google Scholar] [CrossRef]
  66. Chang, C.; Worley, B.L.; Hempel, N. Extracellular glutathione peroxidase GPx3 and its role in cancer. Cancers 2020, 12, 2197. [Google Scholar] [CrossRef]
  67. Fontelles, C.C.; Ong, T.P. Selenium and breast cancer risk: Focus on cellular and molecular mechanisms. Adv. Cancer Res. 2017, 136, 173–192. [Google Scholar]
  68. Diamond, A.M. Selenoproteins of the human prostate: Unusual properties and role in cancer etiology. Biol. Trace Elem. Res. 2019, 192, 51–59. [Google Scholar] [CrossRef]
  69. Li, M.; Cheng, W.; Li, H. Selenoprotein K mediates the proliferation, migration, and invasion of human choriocarcinoma cells by negatively regulating human chorionic gonadotropin expression via ERK, p38 MAPK, and Akt signaling pathway. Biol. Trace Elem. Res. 2018, 184, 47–59. [Google Scholar] [CrossRef]
  70. Marciel, M.P.; Hoffmann, P.R. Molecular mechanisms by which selenoprotein K regulates immunity and cancer. Biol. Trace Elem. Res. 2019, 192, 60–68. [Google Scholar] [CrossRef]
  71. Ben, S.B.; Peng, B.; Chen, C.L. Overexpression of selenoprotein SelK in BGC-823 cells inhibits cell adhesion and migration. Biochemistry 2015, 80, 1344–1353. [Google Scholar] [CrossRef] [PubMed]
  72. Michaelis, M.; Gralla, O.; Schomburg, L. Selenoprotein P in seminal fluid is a novel biomarker of sperm quality. Biochem. Biophys. Res. Commun. 2014, 443, 905–910. [Google Scholar] [CrossRef] [PubMed]
  73. Mojadadi, A.; Au, A.; Ahmad, G. Role for selenium in metabolic homeostasis and human reproduction. Nutrients 2021, 13, 3256. [Google Scholar] [CrossRef] [PubMed]
  74. Flohé, L. Selenium in mammalian spermiogenesis. Biol. Chem. 2007, 388, 987–995. [Google Scholar] [CrossRef]
  75. Qazi, I.H.; Angel, C.; Zhou, G. Role of selenium and selenoproteins in male reproductive function: A review of past and present evidences. Antioxidants 2019, 8, 268. [Google Scholar] [CrossRef] [Green Version]
  76. Qazi, I.H.; Angel, C.; Zhou, G.B. Selenium, selenoproteins, and female reproduction: A review. Molecules 2018, 23, 3053. [Google Scholar] [CrossRef] [Green Version]
  77. Avery, J.C.; Hoffmann, P.R. Selenium, Selenoproteins, and immunity. Nutrients 2018, 10, 1203. [Google Scholar] [CrossRef] [Green Version]
  78. Santos, L.R.; Neves, C.; Soares, P. Selenium and selenoproteins in immune mediated thyroid disorders. Diagnostics 2018, 8, 70. [Google Scholar] [CrossRef] [Green Version]
  79. Lee, H.J.; Li, C.W.; Tomer, Y. Immunogenetics of autoimmune thyroid diseases: A comprehensive review. J. Autoimmun. 2015, 64, 82–90. [Google Scholar] [CrossRef] [Green Version]
  80. Lee, B.C.; Lee, S.G.; Gladyshev, V.N. Selenoprotein MsrB1 promotes anti-inflammatory cytokine gene expression in macrophages and controls immune response in vivo. Sci. Rep. 2017, 7, 5119. [Google Scholar] [CrossRef]
  81. Huang, Z.; Rose, A.H.; Hoffmann, P.R. The role of selenium in inflammation and immunity: From molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 2012, 16, 705–743. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Lewis, S.M.; Williams, A.; Eisenbarth, S.C. Structure and function of the immune system in the spleen. Sci. Immunol. 2019, 4, eaau6085. [Google Scholar] [CrossRef]
  83. Ding, D.; Mou, D.; Feng, B. Maternal organic selenium supplementation alleviates LPS induced inflammation, autophagy and ER stress in the thymus and spleen of offspring piglets by improving the expression of selenoproteins. Food Funct. 2021, 12, 11214–11228. [Google Scholar] [CrossRef]
  84. Arbogast, S.; Ferreiro, A. Selenoproteins and protection against oxidative stress: Selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis. Antioxid. Redox Signal. 2010, 12, 893–904. [Google Scholar] [CrossRef] [PubMed]
  85. Yang, Z.; Liu, C.; Li, S. Selenium deficiency mainly influences antioxidant selenoproteins expression in broiler immune organs. Biol. Trace Elem. Res. 2016, 172, 209–221. [Google Scholar] [CrossRef] [PubMed]
  86. Krehl, S.; Loewinger, M.; Brigelius-Flohé, R. Glutathione peroxidase-2 and selenium decreased inflammation and tumors in a mouse model of inflammation-associated carcinogenesis whereas sulforaphane effects differed with selenium supply. Carcinogenesis 2012, 33, 620–628. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Hariharan, S.; Dharmaraj, S. Selenium and selenoproteins: It’s role in regulation of inflammation. Inflammopharmacology 2020, 28, 667–695. [Google Scholar] [CrossRef] [PubMed]
  88. Chi, Q.; Zhang, Q.; Li, S. Roles of selenoprotein S in reactive oxygen species-dependent neutrophil extracellular trap formation induced by selenium-deficient arteritis. Redox Biol. 2021, 44, 102003. [Google Scholar] [CrossRef]
  89. Shchedrina, V.A.; Zhang, Y.; Gladyshev, V.N. Structure-function relations, physiological roles, and evolution of mammalian ER-resident selenoproteins. Antioxid. Redox Signal. 2010, 12, 839–849. [Google Scholar] [CrossRef]
  90. Varlamova, E.G. Participation of selenoproteins localized in the ER in the processes occurring in this organelle and in the regulation of carcinogenesis-associated processes. J. Trace Elem. Med. Biol. 2018, 48, 172–180. [Google Scholar] [CrossRef]
  91. Addinsall, A.B.; Wright, C.R.; Stupka, N. Emerging roles of endoplasmic reticulum-resident selenoproteins in the regulation of cellular stress responses and the implications for metabolic disease. Biochem. J. 2018, 475, 1037–1057. [Google Scholar] [CrossRef] [PubMed]
  92. Pitts, M.W.; Hoffmann, P.R. Endoplasmic reticulum-resident selenoproteins as regulators of calcium signaling and homeostasis. Cell Calcium. 2018, 70, 76–86. [Google Scholar] [CrossRef] [PubMed]
  93. Irmak, S. Effects of selenium application on plant growth and some quality parameters in peanut (Arachis hypogaea). Pak. J. Biol. Sci. 2017, 20, 92–99. [Google Scholar] [CrossRef] [PubMed]
  94. Saeedi, M.; Soltani, F.; Baldermann, S. Selenium fortification alters the growth, antioxidant characteristics and secondary metabolite profiles of cauliflower (Brassica oleracea var. botrytis) cultivars in hydroponic culture. Plants 2021, 10, 1537. [Google Scholar]
  95. Jia, L.; Wang, T.; Cui, J. Protective effect of selenium-enriched red radish sprouts on carbon tetrachloride-induced liver injury in mice. J. Food Sci. 2019, 84, 3027–3036. [Google Scholar] [CrossRef]
  96. Smits, J.E.; Krohn, R.M.; Raqib, R. Food as medicine: Selenium enriched lentils offer relief against chronic arsenic poisoning in Bangladesh. Environ. Res. 2019, 176, 108561. [Google Scholar] [CrossRef]
  97. Zhang, X.; Xia, H.; Huang, B. Effect of selenium-enriched kiwifruit on body fat reduction and liver protection in hyperlipidaemic mice. Food Funct. 2021, 12, 2044–2057. [Google Scholar] [CrossRef]
  98. Fisinin, V.I.; Papazyan, T.T.; Surai, P.F. Producing selenium-enriched eggs and meat to improve the selenium status of the general population. Crit. Rev. Biotechnol. 2009, 29, 18–28. [Google Scholar] [CrossRef]
  99. Lu, J.; Qu, L.; Wang, K.H. Comparison of dynamic change of egg selenium deposition after feeding sodium selenite or selenium-enriched yeast. Poult. Sci. 2018, 97, 3102–3108. [Google Scholar] [CrossRef]
  100. Lu, J.; Qu, L.; Wang, K.H. Efficacy evaluation of selenium-enriched yeast in laying hens: Effects on performance, egg quality, organ development, and selenium deposition. Poult. Sci. 2020, 99, 6267–6277. [Google Scholar] [CrossRef]
  101. Hou, L.; Qiu, H.; Qin, S. Selenium-enriched saccharomyces cerevisiae improves the meat quality of broiler chickens via activation of the glutathione and thioredoxin systems. Poult. Sci. 2020, 99, 6045–6054. [Google Scholar] [CrossRef] [PubMed]
  102. Mattioli, S.; Dal, B.A.; Proietti, P. Use of Selenium-enriched olive leaves in the feed of growing rabbits: Effect on oxidative status, mineral profile and selenium speciation of longissimus dorsi meat. J. Trace Elem. Med. Biol. 2019, 51, 98–105. [Google Scholar] [CrossRef] [PubMed]
  103. Mrázová, J.; Gažarová, M.; Bobček, B. The effect of consumption of pork enriched by organic selenium on selenium status and lipid profile in blood serum of consumers. J. Environ. Sci. Health B 2020, 55, 69–74. [Google Scholar] [CrossRef] [PubMed]
  104. Skalickova, S.; Milosavljevic, V.; Adam, V. Selenium nanoparticles as a nutritional supplement. Nutrition 2017, 33, 83–90. [Google Scholar] [CrossRef] [PubMed]
  105. Gangadoo, S.; Dinev, I.; Stanley, D. Nanoparticles of selenium as high bioavailable and non-toxic supplement alternatives for broiler chickens. Environ. Sci Pollut. Res. Int. 2020, 27, 16159–16166. [Google Scholar] [CrossRef]
  106. Hu, S.; Hu, W.; Wang, J. Construction and structure-activity mechanism of polysaccharide nano-selenium carrier. Carbohydr. Polym. 2020, 236, 116052. [Google Scholar] [CrossRef]
  107. Ullah, A.; Yin, X.; Naveed, M. Biosynthesis of selenium nanoparticles (via Bacillus subtilis BSN313), and their isolation, characterization, and bioactivities. Molecules 2021, 26, 5559. [Google Scholar] [CrossRef]
  108. Sun, J.; Wei, C.; Liu, J. Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer’s disease. Biomaterials 2019, 197, 417–431. [Google Scholar] [CrossRef]
Figure 1. Biological role of Se.
Figure 1. Biological role of Se.
Antioxidants 11 00973 g001
Figure 2. Metabolism of Se element.
Figure 2. Metabolism of Se element.
Antioxidants 11 00973 g002
Figure 3. Synthesis of selenoproteins.
Figure 3. Synthesis of selenoproteins.
Antioxidants 11 00973 g003
Figure 4. Selenoproteins regulate the health of many organs.
Figure 4. Selenoproteins regulate the health of many organs.
Antioxidants 11 00973 g004
Figure 5. Selenoproteins regulate disease-related signaling pathways.
Figure 5. Selenoproteins regulate disease-related signaling pathways.
Antioxidants 11 00973 g005
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ye, R.; Huang, J.; Wang, Z.; Chen, Y.; Dong, Y. The Role and Mechanism of Essential Selenoproteins for Homeostasis. Antioxidants 2022, 11, 973. https://doi.org/10.3390/antiox11050973

AMA Style

Ye R, Huang J, Wang Z, Chen Y, Dong Y. The Role and Mechanism of Essential Selenoproteins for Homeostasis. Antioxidants. 2022; 11(5):973. https://doi.org/10.3390/antiox11050973

Chicago/Turabian Style

Ye, Ruihua, Jiaqiang Huang, Zixu Wang, Yaoxing Chen, and Yulan Dong. 2022. "The Role and Mechanism of Essential Selenoproteins for Homeostasis" Antioxidants 11, no. 5: 973. https://doi.org/10.3390/antiox11050973

APA Style

Ye, R., Huang, J., Wang, Z., Chen, Y., & Dong, Y. (2022). The Role and Mechanism of Essential Selenoproteins for Homeostasis. Antioxidants, 11(5), 973. https://doi.org/10.3390/antiox11050973

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop